RITUXIMAB AND CYCLOPHOSPHAMIDE COMPARISON FOR EFFICACY AND SAFETY IN THE PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE

被引：4
|
作者：
Koneva, Olga [1 ]
Ananyeva, Lidia P. [1 ]
Garzanova, Liudmila [1 ]
Desinova, Oxana [1 ]
Ovsyannikova, Olga [1 ]
Starovoytova, Mayya [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.6816
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0187
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF THE EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE (SP) AND RITUXIMAB (RTM) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    CHEST, 2020, 157 (06) : 373A - 373A
  • [2] COMPARISON OF THE EFFICACY OF TWO RITUXIMAB REGIMENS IN THE PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga
    Ananyeva, Lidia P.
    Garzanova, Liudmila
    Desinova, Oxana
    Ovsyannikova, Olga
    Starovoytova, Mayya
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 450 - 450
  • [3] RITUXIMAB AND IMMUNOSUPPRESSANTS IN PATIENTS WITH SYSTEMIC SCLERODERMA WITH INTERSTITIAL LUNG DISEASE: A COMPARISON OF EFFICACY AND SAFETY
    Koneva, Olga
    Ananyeva, Lidia
    Garzanova, Liudmila
    Desinova, Oxana
    Ovsynnikova, Olga
    Starovoytova, Mayya
    CHEST, 2021, 160 (04) : 2149A - 2149A
  • [4] Efficacy of Rituximab in Systemic Sclerosis with Interstitial Lung Disease
    Onat, Ahmet Mesut
    Zengin, Orhan
    Aksoy, Savas
    Onder, Mustafa Erkut
    Sacinti, Koray Gorkem
    Kisacik, Bunyamin
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] Efficacy of the combined therapy with Rituximab plus Cyclophosphamide versus Cyclophosphamide as Monotherapy in Systemic Sclerosis-Associated Interstitial Lung Disease
    Tejeda-Andrade, C. F.
    Villalpando-Gomez, Y.
    Gamez-Nava, J., I
    Castro-Lizano, N.
    Rocha-Munoz, A. D.
    Cardona, Munoz E. G.
    Gonzalez-Lopez, L.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1193 - 1193
  • [6] Interstitial lung disease associated with systemic sclerosis -: What is the evidence for efficacy of cyclophosphamide?
    Berezne, Alice
    Valeyre, Dominique
    Ranque, Brigitte
    Guillevina, Loic
    Mouthon, Luc
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 271 - 284
  • [7] STUDY OF RITUXIMAB EFFICACY PREDICTORS IN PATIENTS WITH SYSTEMIC SCLEROSIS WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga
    Ananyeva, Lidia
    Garzanova, Liudmila
    Desinova, Oxana
    Ovsynnikova, Olga
    Starovoytova, Mayya
    CHEST, 2021, 160 (04) : 2148A - 2148A
  • [8] EFFICACY AND SAFETY OF LONG TERM CYCLOPHOSPHAMIDE TREATMENT FOR INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS
    Kwon, H. M.
    Karig, E. H.
    Go, D. J.
    Park, J. K.
    Lee, E. Y.
    Song, Y. W.
    Lee, H. -J.
    Lee, E. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1011 - 1011
  • [9] Analysis of patients with interstitial lung disease associated to Systemic Sclerosis treated with cyclophosphamide
    Arreguy Nogueira, Luiz Paulo
    Mancuzo, Eliane
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [10] Efficacy of Rituximab Versus Cyclophosphamide and Mycophenolate for the Treatment of Interstitial Lung Disease in Systemic Sclerosis: A Systematic Review
    Parikh, Aneri
    Francis, Aida J.
    Sreenivasan, Chithra
    Pandey, Manorama
    AlQassab, Osamah
    Kanthajan, Tatchaya
    AlEdani, Esraa M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
12345